-
International Cost-Benefit Analysis Applications for Climate Adaptation: A Systematic Review
Nir Becker, Tel Hai College; and Gur Angel, Hebrew University of Jerusalem
show abstract
This paper systematically reviews international applications of cost-benefit analysis (CBA) in climate change adaptation, addressing persistent gaps in methodological practice, geographical and sectoral coverage, and policy relevance. The central research questions guide a global synthesis of adaptation CBAs published from 2000 to 2025: What are the prevailing methodological approaches and valuation techniques? Which adaptation measures are most frequently analyzed, and what do their economic efficiency results reveal? What challenges and limitations complicate the use of CBA in adaptation contexts, especially concerning uncertainty, data scarcity, non-market valuation, and equity?
The review draws on 127 studies spanning 62 countries and multiple sectors, using a standardized template for data extraction and rigorous inclusion/exclusion criteria. It analyzes frameworks, discount rates, non-market value integration, treatment of uncertainty, and baseline scenario development across infrastructural, nature-based, policy, behavioral, and hybrid adaptation measures. Benefit-cost ratios and net present values are compared across regions and sectors to identify geographic disparities, sectoral trends, and context-dependent patterns in economic efficiency.
Novel contributions of this study include a comprehensive mapping of international practices, equity-sensitive evaluation of distributional impacts, and a synthesis of emerging approaches such as real options analysis and multi-criteria decision tools integrated with CBA. Results highlight both economically efficient adaptation investments and persistently understudied regions and sectors. The discussion details practical, ethical, and methodological constraints - including intergenerational discounting and the valuation of non-market benefits - and recommends avenues for robust data collection, methodological standardization, and policy integration.
This review offers actionable insights for policymakers, researchers, and practitioners seeking to advance the use of CBA in climate adaptation, with implications for strategic investment, cross-regional learning, and the evolution of benefit-cost analysis in environmental decision-making.
-
“From Vulnerability to Value: Integrating Climate Justice, Heritage, and Clean Energy into Global Benefit–Cost Analysis”
Aamir Ashfaq Khan, ABT Associates
show abstract
As the world faces accelerating climate and energy crises, countries in the Global South stand at the frontlines of vulnerability yet also at the frontier of innovation. This paper redefines the application of Benefit Cost Analysis (BCA) through an integrated lens of climate justice, heritage conservation, and clean energy transition, using empirical insights from Pakistan’s Climate Hub Forum (CHF) initiatives.
The study evaluates three interlinked domains that shape sustainable and regenerative policy outcomes:
Clean Energy Transition: Applying BCA to decentralized renewable energy systems, assessing their fiscal viability, social inclusivity, and long-term resilience across rural and peri urban regions.
Climate and Circular Economy Models: Quantifying the ecological and economic returns of CHF’s One Million Trees and Towards Zero Waste programs, offering scalable frameworks for low-carbon community transformation.
Heritage-Led Regeneration: A pioneering analysis of heritage eco-tourism in the Gandhara Civilization (Taxila)the world’s first university revealing how cultural assets can drive economic diversification, identity preservation, and green growth.
By embedding social equity and intergenerational justice within BCA, this research challenges conventional efficiency-based evaluation, presenting a more human-centered economic narrative. The analysis demonstrates how climate-vulnerable nations can transform risks into regenerative value systems by linking policy, culture, and innovation.
Ultimately, the paper positions the Global South not as a passive recipient of aid, but as an active architect of new economic paradigms where benefit–cost frameworks advance both efficiency and empathy. These insights provide actionable guidance for international agencies, governments, and development institutions seeking inclusive, evidence-based pathways toward a resilient and equitable global economy.
-
Probabilistic dose-response methods for non-cancer health benefits analysis
Anna Belova, ICF Incorporated; Greg Paoli, Risk Sciences International; Kate Munson, ICF Incorporated; Emma Hartnett, Risk Sciences International; and Franco Momoli, Risk Sciences International
show abstract
Toxicological studies provide data on the effects of exposure to environmental chemicals on non-cancer health endpoints that are used for reference dose/concentration development. However, epidemiological evidence for non-cancer endpoints, particularly dose-response relationships necessary for quantitative risk analysis, is frequently lacking. Consequently, non-cancer health impacts are often described qualitatively in benefit-cost analyses (BCAs) of environmental regulations, leading to underestimation of the monetized health benefits. The probabilistic dose-response methodology was developed and explored as a means to estimate a probabilistic version of a reference dose based on toxicological data, where there is explicit application of the desired level of confidence and an explicit incidence goal for the health effect in question. This methodology can be extended to applications in formal quantitative risk analysis and human health benefit analysis.
Building on this methodology, we develop risk and benefits analysis case studies for three chemicals (1,4-dioxane, 1,3-butadiene, and vinyl chloride) and three non-cancer health outcomes (chronic kidney disease, cirrhosis, and birth weight). In that, we combine exposure assessment and dose-response assessment via Monte Carlo simulation to estimate the incidence of toxicological health endpoints (kidney necrosis, liver polymorphism, and 5% mean increase in fetal weight). The endpoint incidence is evaluated under a baseline scenario and under a hypothetical exposure reduction scenario. These results are then translated into non-cancer health outcomes and used in an integrated health impact model to estimate the societal benefits of the hypothetical policy action. Sensitivity analysis and uncertainty analysis demonstrate which model inputs drive the benefit estimates.
We demonstrate the extension of the probabilistic dose-response methodology to the characterization of non-cancer health risks in exposed populations and estimation of monetized health benefits associated with policy changes. The key challenge of this analysis lies in the translation of the toxicological endpoints to the human health outcomes that can be valued.
-
Reducing PFAS in Drinking Water and Perinatal Health
Wes Austin, Environmental Protection Agency
show abstract
Per- and polyfluoroalkyl substances (PFAS), often dubbed "forever chemicals" due to their resistance to degradation, are frequently found in drinking water sources, and exposure to PFAS has been linked to a litany of health effects. PFAS exposure can impact fertility, cross the placental barrier, and lead to adverse developmental outcomes like increased risk of gestational diabetes, gestational hypertension, preeclampsia, fetal loss, low birthweight, and infant mortality. We study the connection between PFAS exposure in drinking water and fetal health using a two-stage least squares instrumental variables approach. In the first stage, we predict changes in PFAS concentrations using the roll-out of state policies that set limits to PFAS in drinking water across nine states from 2018-2021. In the second stage, we use these policy-induced reductions in PFAS concentrations to predict changes in perinatal health in communities served by drinking water systems with PFAS detections. Identification relies on state policy-induced reductions in PFAS at systems that were previously above maximum contaminant level thresholds. Using data on water system treatment practices, we show reductions in PFAS resulting from state policies can be partially explained by adoption of improved water treatment technologies. We use the CDC's national individual-level birth certificates data to investigate a wide range of perinatal health outcomes including birthweight, likelihood of low birthweight, gestation length, likelihood of preterm gestation, gestational hypertension, gestational diabetes and presence of congenital anomalies. We find that a one part-per-trillion reduction in PFOA or PFOS in drinking water leads to a 3.5 - 7.2 gram increase in birthweight for affected newborns. We also explore heterogeneity in our primary outcomes across areas with greater likelihood of relying on private domestic wells and propensity to purchase bottled water.